| ||If you have any feedback on how we can make our new website better please do contact us. We would like to hear from you.|| |
Roof and roof flashing is one of the
most important aspects of a home in order to protect the home from the
elements. The roof is one of the most important areas of concern for home
owners and buyers. Most often, home owners or buyers are unaware of the
condition of a roof simply because it is an area not accessible or easy to view
from the ground. The condition of a roof can be compromised during the
construction process or over the course of time. Improper handling by the roofing contractor,
tools, foot traffic, scuffing, improper shingle tab exposure, torn shingles and
inclement weather are all items that affect your roofs condition.
As technology develops and improves,
so does our inspection techniques. We implement the use of drone technology
with a 2.7K camera to fly over your home. The ability to video your roof with
precise accuracy gives you the advantage and benefit of a clear picture of the
The drone allows viewing of roof defects that are just not possible from the ground. Below are examples of Improper Shingle Tab Installation, Torn Shingles at the Ridge, and Missing Flue Cap at a Vent Hood.
Rosuvastatin is used for lowering high cholesterol and triglycerides in certain patients.
Rosuvastatin 10mg $162.94 - $1.81 Per pill
Rosuvastatin 10mg $302.22 - $1.68 Per pill
- Broken Hill
- Powell River
- Port Alberni
Rosuvastatin generic when in fact, it was more expensive than a new high-quality statin.
But I don't think it's just with statin drugs. Even if we took out the low-quality or off-patent drugs, prices of the drugs would be relatively low, I think, if we take into account the price differences between companies.
There's nothing in the study so far that addresses the issue of generic-drug prices or the issue of generics and brand-name drugs for heart disease. Are there better ways of looking at price differences between brand-name and generic drugmakers or are they the same?
I think that's a really interesting point. I think you have to take this issue in context.
The study finds that when you look at the difference between brand and generic manufacturers the difference in price is substantial. For example, if you looked at the price of a high quality statin, for the generic version that will only be $29.95 or something like that and for the name brand I think you could price that $35 or something like that. So there is a substantial cost differential between these two formulations, so I think it's not surprising that we found that.
Then, the way I would go down the road in terms of generics and brand-name drugs is in terms of the fact that it's really only about the drug's active ingredient. Because if the drug has a bad in it, you should price that down and you shouldn't expect that brand-name drug companies are able to sell an active ingredient doctors at a price that's substantially lower than the price of generic drugs.
I think the fact that in most circumstances, generics do have similar, lower active ingredient costs to brand drugs, then you don't see that kind of difference between brand and generic drugs. so there's really no good evidence that there's a substantial difference, or even small in price.
But you're also looking at generics now; you're generic versions of existing drugs, aren't you?
Yeah, that's right. And one thing the study does is it examines what gen